KPIs & Operating Metrics(New)

Active Registered Patients Adjusted Ebitda Adjusted Gross Margin Breakdown %Adjusted Gross Margin Breakdown (Annual)Adjusted Gross Margin Breakdown Core Cannabis %Adjusted Gross Profit Breakdown Adjusted Gross Profit Breakdown (Annual)Adjusted Gross Profit Breakdown Core Cannabis Asp By End Market (Per Gram)Asp By Product Category Biological Assets Breakdown Of Assets Cannabis Revenue By Product Category Cannabis Segment Operating Statistics Cannabis Segment Operating Statistics Annual Cannabis Vs Non Cannabis Revenue Contractual Obligations Annual Core Cannabis Revenue Breakdown Core Cannabis Revenue Mix Cost Of Sales Cost Per Gram Medical Cannabis Disaggregated Cannabis Revenue Excise Taxes Gross Margin By End Market %Gross Margin By Region On Gross Revenue %Gross Profit Gross Profit %Gross Profit By Region Gross Profit By Region (Annually)Gross Revenue By Segment Gross Revenue By Segment %Inventory By Segment Local Vs Outsourcing Production Non Current Assets By Geography Non Gaap Profitability Annual Non Gaap Profitability Annual %OPEX Segregation Outsourced Supply Cost Production Vs Sales Property, Plant And Equipment (Gross)Purchase Commitments Purchase Commitments Annual Revenue By Business Vertical Revenue By Business Vertical Mix %Revenue By End Market Revenue By Geography Annual Revenue By Geography Annual %Revenue By Recognition Of Timing Revenue By Recognition Of Timing %Revenue By Region (Gross) Annual Revenue By Region (Net)Revenue By Region (Net) %Revenue By Segment Revenue By Segment %Revenue By Segment Annual Revenue By Segment Annual %Revenue (Gross) By Business Vertical Revenue Gross Vs Net Revenue Segregation Revenue Segregation %Sales Volume Kg (Cannabis)

Balance Sheet

Cash Flow Statement

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Depreciation & Amortization (IS)EBIAT Gross Profit Loans and Notes Receivables Long-Term Debt Issuances Long-Term Debt Repayments Pension (IS)Receivables - Net Receivables - Other Receivables Refunds Shares Issued Shares Outstanding Shares Outstanding Short-Term Debt repayments

Aurora Cannabis (ACB) Gross Profit (2016 - 2026)

Aurora Cannabis has reported Gross Profit over the past 9 years, most recently at $33.4 million for Q4 2025.

Quarterly Gross Profit fell 37.68% to $33.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $96.3 million through Dec 2025, down 35.96% year-over-year, with the annual reading at $130.7 million for FY2025, 33.75% up from the prior year.
Gross Profit was $33.4 million for Q4 2025 at Aurora Cannabis, up from $23.5 million in the prior quarter.
Over five years, Gross Profit peaked at $53.6 million in Q4 2024 and troughed at -$67.5 million in Q1 2021.
The 5-year median for Gross Profit is $19.7 million (2025), against an average of $13.9 million.
Year-over-year, Gross Profit plummeted 430.33% in 2021 and then skyrocketed 3585.8% in 2023.
A 5-year view of Gross Profit shows it stood at $4.4 million in 2021, then tumbled by 313.86% to -$9.5 million in 2022, then surged by 293.83% to $18.4 million in 2023, then surged by 192.33% to $53.6 million in 2024, then crashed by 37.68% to $33.4 million in 2025.
Per Business Quant, the three most recent readings for ACB's Gross Profit are $33.4 million (Q4 2025), $23.5 million (Q3 2025), and $20.2 million (Q2 2025).